Abstract
cAMP has been found to play a role in mediating the negative regulation of cell motility, although its underlying molecular mechanism remains poorly understood. By using CHO (Chinese-hamster ovary) cells that express the EP2 subtype of PGE2 (prostaglandin E2) receptors, we provide evidence that an increase in cellular cAMP content leads to inhibition of cellular Rac activity, which serves as a mechanism for this negative regulation. In CHO cells expressing EP2, but not in vector control cells, PGE2 dose-dependently inhibited chemotaxis towards IGF-I (insulin-like growth factor-I), which is a Rac-dependent process, with the maximal 75% inhibition observed at 10(-8) M PGE2. EP2 stimulation failed to inhibit tyrosine phosphorylation either of IGF-I receptor or IRS-1 (insulin receptor substrate-1), or activation of phosphoinositide 3-kinase or Akt in response to IGF-I, but potently and dose-dependently inhibited IGF-I-induced activation of cellular Rac activity and membrane ruffling. However, PGE2 failed to inhibit Val12-Rac-induced membrane ruffling. Similar to the case of CHO cells, PGE2 inhibited PDGF (platelet-derived growth factor)-induced Rac activation and chemotaxis in vascular smooth muscle cells endogenously expressing EP...Continue Reading
References
Apr 16, 1991·Biochimica Et Biophysica Acta·M Stoker, E Gherardi
Oct 1, 1995·Circulation Research·T HorioT Takeda
Feb 9, 1996·Cell·D A Lauffenburger, A F Horwitz
Dec 1, 1995·British Journal of Pharmacology·R A Armstrong
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·K YasunariJ Yoshikawa
Feb 7, 1998·Science·A Hall
Sep 30, 1998·British Journal of Haematology·B Z PaulS B Sheth
Oct 9, 1998·The Journal of Biological Chemistry·H OkamotoY Takuwa
Dec 16, 1998·Nature·J de RooijJ L Bos
Oct 3, 1999·Physiological Reviews·S NarumiyaF Ushikubi
Nov 30, 2000·Molecular and Cellular Biology·H OkamotoY Takuwa
Aug 29, 2001·The Journal of General Physiology·J WangS A Siegelbaum
Oct 19, 2001·The Journal of Biological Chemistry·K L O'Connor, A M Mercurio
Feb 28, 2002·Circulation Research·Yasuji RyuYoh Takuwa
Aug 20, 2002·Nature Medicine·Manjiri M BakreJudith A Varner
Feb 18, 2003·Molecular and Cellular Biology·Naotoshi SugimotoYoh Takuwa
Mar 8, 2003·Pigment Cell Research·Glynis Scott, Sonya Leopardi
Jun 18, 2003·The Journal of Biological Chemistry·Kayo ArikawaYoh Takuwa
Jun 24, 2003·Nature Cell Biology·Marjorie MailletFrank Lezoualc'h
Dec 6, 2003·Science·Anne J RidleyAlan Rick Horwitz
Jan 9, 2004·The Journal of Biological Chemistry·Soichiro UsuiYoh Takuwa
Citations
Jun 16, 2009·Nature Neuroscience·Anna G OrrStephen F Traynelis
Mar 2, 2011·Journal of Neurotrauma·Feng BaoLynne C Weaver
May 16, 2008·Cardiovascular Research·Shin-Ichiro TakashimaYoh Takuwa
Feb 26, 2016·Science Signaling·Chinmay R SurveAlan V Smrcka
May 12, 2012·Prostaglandins & Other Lipid Mediators·David M AronoffPeter Mancuso
Jun 21, 2008·Brain Research·Takayuki NaganoMotohiko Takemura
Jun 23, 2012·Microbiology·Antonio López-GómezJunkal Garmendia
Aug 22, 2007·Cell Host & Microbe·Jeongmin SongSoman N Abraham
Feb 1, 2008·Biology of Reproduction·Catalin NicolaChandan Chakraborty
Jul 28, 2016·BioFactors·Xiao-Fei ShenNing Huang
Jun 8, 2012·BioFactors·Yoh TakuwaNoriko Takuwa
Oct 5, 2010·Integrative Biology : Quantitative Biosciences From Nano to Macro·Antoine A Khalil, Peter Friedl
Jul 15, 2020·Cell Biology International·Weiyan MoMin Liang
Oct 5, 2016·Experimental and Therapeutic Medicine·Hao ChengQing Ji
Aug 3, 2016·The Journal of Biological Chemistry·Douglas BarrowsRamon Parsons
Dec 12, 2019·Cell Transplantation·Xiao ZhangBin Ling
Dec 21, 2014·Molecular Cancer Therapeutics·Béatrice DiratFrédéric Bost